Professur für Tumorimmunologie (Schwerpunkt Systembiologie)

Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al. Journal article, Letter Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment (2023) Petzold A, Steeb T, Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article, Review article Identifying biomarkers and novel therapeutic targets in uveal melanoma (2023) Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections (2023) Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, et al. Journal article Integration of transcriptomics data into agent-based models of solid tumor metastasis (2023) Retzlaff J, Lai X, Berking C, Vera J Journal article A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer (2023) Zhang L, Fan S, Vera J, Lai X Journal article Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression. (2023) Singh N, Khan FM, Bala L, Vera J, Wolkenhauer O, Pützer B, Logotheti S, Gupta SK Journal article Glaucoma-TrEl: A web-based interactive database to build evidence-based hypotheses on the role of trace elements in glaucoma (2022) Choudhari JK, Eberhardt M, Chatterjee T, Hohberger B, Vera J Journal article Melanoma 2.0. Skin cancer as a paradigm for emerging diagnostic technologies, computational modelling and artificial intelligence (2022) Vera J, Lai X, Baur A, Erdmann M, Gupta S, Gutta C, Heinzerling L, et al. Journal article, Review article Single-cell Transcriptome Analysis and clonal Kinetics in a Patient after CD19.CAR-T Cell Therapy (2022) Lischer C, Eisenhauer N, Aigner M, Jacobs B, Schletter M, Gebhard C, Rehli M, et al. Conference contribution